PubMed

Escape from autologous humoral immunity of HIV-1 is not associated with a decrease in replicative capacity.

Bunnik EM, Lobbrecht MS, van Nuenen AC, Schuitemaker H.

Virology. 2009 Nov 26. [Epub ahead of print]PMID: 19945135 [PubMed - as supplied by publisher]

High Prevalence of Neutralizing Activity against Multiple Unrelated HIV-1 Subtype B Variants in Sera from HIV-1 Subtype B Infected Individuals: Evidence for Subtype Specific Rather than Strain Specific Neutralizing Activity.

van Gils MJ, Edo-Matas D, Schweighardt B, Wrin T, Schuitemaker H.

J Gen Virol. 2009 Sep 30. [Epub ahead of print]PMID: 19793903 [PubMed - as supplied by publisher]Related articles

Correlation between HIV-1 seropositivity and prevalence of a gamma-secretase polymorphism in two distinct ethnic populations.

van Loo KM, van Schijndel JE, van Zweeden M, van Manen D, Trip MD, Petersen DC, Schuitemaker H, Hayes VM, Martens GJ.

J Med Virol. 2009 Nov;81(11):1847-51.PMID: 19774691 [PubMed - in process]Related articles

Prevalence of cross-reactive HIV-1-neutralizing activity in HIV-1-infected patients with rapid or slow disease progression.

van Gils MJ, Euler Z, Schweighardt B, Wrin T, Schuitemaker H.

AIDS. 2009 Nov 27;23(18):2405-14.PMID: 19770692 [PubMed - in process]Related articles

Comparison of human immunodeficiency virus type 1 tropism profiles in clinical samples by the Trofile and MT-2 assays.

Coakley E, Reeves JD, Huang W, Mangas-Ruiz M, Maurer I, Harskamp AM, Gupta S, Lie Y, Petropoulos CJ, Schuitemaker H, van 't Wout AB.

Antimicrob Agents Chemother. 2009 Nov;53(11):4686-93. Epub 2009 Aug 17.PMID: 19687240 [PubMed - in process]Related articles

Changing sensitivity to broadly neutralizing antibodies b12, 2G12, 2F5, and 4E10 of primary subtype B human immunodeficiency virus type 1 variants in the natural course of infection.

Bunnik EM, van Gils MJ, Lobbrecht MS, Pisas L, van Nuenen AC, Schuitemaker H.

Virology. 2009 Aug 1;390(2):348-55. Epub 2009 Jun 17.PMID: 19539340 [PubMed - indexed for MEDLINE]Related articles

Donor variation in in vitro HIV-1 susceptibility of monocyte-derived macrophages.

Bol SM, van Remmerden Y, Sietzema JG, Kootstra NA, Schuitemaker H, van't Wout AB.

Virology. 2009 Aug 1;390(2):205-11. Epub 2009 Jun 16.PMID: 19535121 [PubMed - indexed for MEDLINE]Related articles

International network for comparison of HIV neutralization assays: the NeutNet report.

Fenyö EM, Heath A, Dispinseri S, Holmes H, Lusso P, Zolla-Pazner S, Donners H, Heyndrickx L, Alcami J, Bongertz V, Jassoy C, Malnati M, Montefiori D, Moog C, Morris L, Osmanov S, Polonis V, Sattentau Q, Schuitemaker H, Sutthent R, Wrin T, Scarlatti G.

PLoS One. 2009;4(2):e4505. Epub 2009 Feb 20.PMID: 19229336 [PubMed - indexed for MEDLINE]Related articlesFree article

Association of HLA-C and HCP5 gene regions with the clinical course of HIV-1 infection.

van Manen D, Kootstra NA, Boeser-Nunnink B, Handulle MA, van't Wout AB, Schuitemaker H.

AIDS. 2009 Jan 2;23(1):19-28.PMID: 19050382 [PubMed - indexed for MEDLINE]Related articles

Recovery of viremic control after superinfection with pathogenic HIV type 1 in a long-term elite controller of HIV type 1 infection.

Rachinger A, Navis M, van Assen S, Groeneveld PH, Schuitemaker H.

Clin Infect Dis. 2008 Dec 1;47(11):e86-9.PMID: 18947331 [PubMed - indexed for MEDLINE]Related articles

HIV-1 viral rebound dynamics after a single treatment interruption depends on time of initiation of highly active antiretroviral therapy.

Steingrover R, Pogány K, Fernandez Garcia E, Jurriaans S, Brinkman K, Schuitemaker H, Miedema F, Lange JM, Prins JM.

AIDS. 2008 Aug 20;22(13):1583-8.PMID: 18670217 [PubMed - indexed for MEDLINE]Related articles

Molecular evolution of human immunodeficiency virus type 1 upon transmission between human leukocyte antigen disparate donor-recipient pairs.

Navis M, Matas DE, Rachinger A, Koning FA, van Swieten P, Kootstra NA, Schuitemaker H.

PLoS One. 2008 Jun 18;3(6):e2422.PMID: 18560583 [PubMed - indexed for MEDLINE]Related articlesFree article

Autologous neutralizing humoral immunity and evolution of the viral envelope in the course of subtype B human immunodeficiency virus type 1 infection.

Bunnik EM, Pisas L, van Nuenen AC, Schuitemaker H.

J Virol. 2008 Aug;82(16):7932-41. Epub 2008 Jun 4.PMID: 18524815 [PubMed - indexed for MEDLINE]Related articlesFree article

CCR5-restricted HIV type 2 variants from long-term aviremic individuals are less sensitive to inhibition by beta-chemokines than low pathogenic HIV type 1 variants.

Blaak H, Boers PH, van der Ende ME, Schuitemaker H, Osterhaus AD.

AIDS Res Hum Retroviruses. 2008 Mar;24(3):473-84.PMID: 18327978 [PubMed - indexed for MEDLINE]Related articles

Isolation and propagation of HIV-1 on peripheral blood mononuclear cells.

van 't Wout AB, Schuitemaker H, Kootstra NA.

Nat Protoc. 2008;3(3):363-70.PMID: 18323807 [PubMed - indexed for MEDLINE]Related articles

A nonprogressive clinical course in HIV-infected individuals expressing human leukocyte antigen B57/5801 is associated with preserved CD8+ T lymphocyte responsiveness to the HW9 epitope in Nef.

Navis M, Schellens IM, van Swieten P, Borghans JA, Miedema F, Kootstra NA, van Baarle D, Schuitemaker H.

J Infect Dis. 2008 Mar 15;197(6):871-9.PMID: 18279072 [PubMed - indexed for MEDLINE]Related articles

The effect of Trim5 polymorphisms on the clinical course of HIV-1 infection.

van Manen D, Rits MA, Beugeling C, van Dort K, Schuitemaker H, Kootstra NA.

PLoS Pathog. 2008 Feb 8;4(2):e18.PMID: 18248091 [PubMed - indexed for MEDLINE]Related articlesFree article

Intravenous immunoglobulin (IVIG) treatment for modulation of immune activation in human immunodeficiency virus type 1 infected therapy-naive individuals.

Vermeulen JN, Prins JM, Bunnik E, Hack CE, Jurriaans S, Miedema F, Lange JM, Schuitemaker H.

AIDS Res Hum Retroviruses. 2007 Nov;23(11):1348-53.PMID: 18184076 [PubMed - indexed for MEDLINE]Related articles

Potential and limitation of UVC irradiation for the inactivation of pathogens in platelet concentrates.

Terpstra FG, van 't Wout AB, Schuitemaker H, van Engelenburg FA, Dekkers DW, Verhaar R, de Korte D, Verhoeven AJ.

Transfusion. 2008 Feb;48(2):304-13. Epub 2007 Nov 19.PMID: 18028277 [PubMed - indexed for MEDLINE]Related articles

Use of Immunological and Viral Parameters to Predict Progression of HIV Infection During Natural Course and Antiretroviral Treatment.

Koot M, van 't Wout AB, Miedema F, Schuitemaker H.

BioDrugs. 1997 Oct;8(4):243-9. No abstract available. PMID: 18020516 [PubMed - in process]Related articles

The presence of the Trim5alpha escape mutation H87Q in the capsid of late stage HIV-1 variants is preceded by a prolonged asymptomatic infection phase.

Kootstra NA, Navis M, Beugeling C, van Dort KA, Schuitemaker H.

AIDS. 2007 Oct 1;21(15):2015-23.PMID: 17885291 [PubMed - indexed for MEDLINE]Related articles

Viral replication capacity as a correlate of HLA B57/B5801-associated nonprogressive HIV-1 infection.

Navis M, Schellens I, van Baarle D, Borghans J, van Swieten P, Miedema F, Kootstra N, Schuitemaker H.

J Immunol. 2007 Sep 1;179(5):3133-43.PMID: 17709528 [PubMed - indexed for MEDLINE]Related articlesFree article

Resistance of surface-dried virus to common disinfection procedures.

Terpstra FG, van den Blink AE, Bos LM, Boots AG, Brinkhuis FH, Gijsen E, van Remmerden Y, Schuitemaker H, van 't Wout AB.

J Hosp Infect. 2007 Aug;66(4):332-8. Epub 2007 Jun 29.PMID: 17601636 [PubMed - indexed for MEDLINE]Related articles

Low immune activation despite high levels of pathogenic human immunodeficiency virus type 1 results in long-term asymptomatic disease.

Choudhary SK, Vrisekoop N, Jansen CA, Otto SA, Schuitemaker H, Miedema F, Camerini D.

J Virol. 2007 Aug;81(16):8838-42. Epub 2007 May 30.PMID: 17537849 [PubMed - indexed for MEDLINE]Related articlesFree article

Susceptibility of recently transmitted subtype B human immunodeficiency virus type 1 variants to broadly neutralizing antibodies.

Quakkelaar ED, van Alphen FP, Boeser-Nunnink BD, van Nuenen AC, Pantophlet R, Schuitemaker H.

J Virol. 2007 Aug;81(16):8533-42. Epub 2007 May 23.PMID: 17522228 [PubMed - indexed for MEDLINE]Related articlesFree article

HIV-1 Subtype C gag-specific T-cell responses in relation to human leukocyte antigens in a diverse population of HIV-infected Ethiopians.

Tsegaye A, Ran L, Wolday D, Petros B, Dorigo W, Piriou E, Messele T, Sanders E, Tilahun T, Eshetu D, Schuitemaker H, Coutinho RA, Miedema F, Borghans J, van Baarle D.

J Acquir Immune Defic Syndr. 2007 Aug 1;45(4):389-400.PMID: 17417101 [PubMed - indexed for MEDLINE]Related articles

Escape of human immunodeficiency virus type 1 from broadly neutralizing antibodies is not associated with a reduction of viral replicative capacity in vitro.

Quakkelaar ED, Bunnik EM, van Alphen FP, Boeser-Nunnink BD, van Nuenen AC, Schuitemaker H.

Virology. 2007 Jul 5;363(2):447-53. Epub 2007 Mar 13.PMID: 17355886 [PubMed - indexed for MEDLINE]Related articles

Antiviral activity of HIV type 1 protease inhibitors nelfinavir and indinavir in vivo is not influenced by P-glycoprotein activity on CD4+ T cells.

Sankatsing SU, Cornelissen M, Kloosterboer N, Crommentuyn KM, Bosch TM, Mul FP, Jurriaans S, Huitema AD, Beijnen JH, Lange JM, Prins JM, Schuitemaker H.

AIDS Res Hum Retroviruses. 2007 Jan;23(1):19-27.PMID: 17263628 [PubMed - indexed for MEDLINE]Related articles

Increased neutralization sensitivity of recently emerged CXCR4-using human immunodeficiency virus type 1 strains compared to coexisting CCR5-using variants from the same patient.

Bunnik EM, Quakkelaar ED, van Nuenen AC, Boeser-Nunnink B, Schuitemaker H.

J Virol. 2007 Jan;81(2):525-31. Epub 2006 Nov 1.PMID: 17079299 [PubMed - indexed for MEDLINE]Related articlesFree article

Viral safety of C1-inhibitor NF.

Terpstra FG, Kleijn M, Koenderman AH, Over J, van Engelenburg FA, Schuitemaker H, van 't Wout AB.

Biologicals. 2007 Jun;35(3):173-81. Epub 2006 Oct 30.PMID: 17071103 [PubMed - indexed for MEDLINE]Related articles

T cell line passage can select for pre-existing neutralization-sensitive variants from the quasispecies of primary human immunodeficiency virus type-1 isolates.

Quakkelaar ED, Beaumont T, van Nuenen AC, van Alphen FP, Boeser-Nunnink BD, van 't Wout AB, Schuitemaker H.

Virology. 2007 Mar 1;359(1):92-104. Epub 2006 Oct 18.PMID: 17052738 [PubMed - indexed for MEDLINE]Related articles

In vitro replication capacity of HIV-2 variants from long-term aviremic individuals.

Blaak H, van der Ende ME, Boers PH, Schuitemaker H, Osterhaus AD.

Virology. 2006 Sep 15;353(1):144-54. Epub 2006 Jun 30.PMID: 16814357 [PubMed - indexed for MEDLINE]Related articles

Impact of CCR5 Delta32/+ deletion on herpes zoster among HIV-1-infected homosexual men.

Krol A, Lensen R, Veenstra J, Prins M, Schuitemaker H, Coutinho RA.

Eur J Epidemiol. 2006;21(6):469-73. Epub 2006 May 16.PMID: 16703416 [PubMed - indexed for MEDLINE]Related articles

Short communication: No detrimental immunological effects of mycophenolate mofetil and HAART in treatment-naive acute and chronic HIV-1-infected patients.

Vrisekoop N, Sankatsing SU, Jansen CA, Roos MT, Otto SA, Schuitemaker H, Lange JM, Prins JM, Miedema F.

AIDS Res Hum Retroviruses. 2005 Dec;21(12):991-6.PMID: 16379601 [PubMed - indexed for MEDLINE]Related articles

CTL escape and increased viremia irrespective of HIV-specific CD4+ T-helper responses in two HIV-infected individuals.

Geels MJ, Jansen CA, Baan E, De Cuyper IM, van Schijndel GJ, Schuitemaker H, Goudsmit J, Pollakis G, Miedema F, Paxton WA, van Baarle D.

Virology. 2006 Feb 5;345(1):209-19. Epub 2005 Oct 21.PMID: 16246391 [PubMed - indexed for MEDLINE]Related articles

Low-level CD4+ T cell activation is associated with low susceptibility to HIV-1 infection.

Koning FA, Otto SA, Hazenberg MD, Dekker L, Prins M, Miedema F, Schuitemaker H.

J Immunol. 2005 Nov 1;175(9):6117-22.PMID: 16237108 [PubMed - indexed for MEDLINE]Related articlesFree article

Determination of co-receptor usage of HIV-1.

Schuitemaker H, Kootstra NA.

Methods Mol Biol. 2005;304:327-32.PMID: 16061986 [PubMed - indexed for MEDLINE]Related articles

Determination of cell tropism of HIV-1.

Kootstra NA, Schuitemaker H.

Methods Mol Biol. 2005;304:317-25.PMID: 16061985 [PubMed - indexed for MEDLINE]Related articles

Isolation, propagation, and titration of human immunodeficiency virus type 1 from peripheral blood of infected individuals.

Schuitemaker H, Kootstra NA.

Methods Mol Biol. 2005;304:17-24.PMID: 16061963 [PubMed - indexed for MEDLINE]Related articles

Natural controlled HIV infection: preserved HIV-specific immunity despite undetectable replication competent virus.

Kloosterboer N, Groeneveld PH, Jansen CA, van der Vorst TJ, Koning F, Winkel CN, Duits AJ, Miedema F, van Baarle D, van Rij RP, Brinkman K, Schuitemaker H.

Virology. 2005 Aug 15;339(1):70-80.PMID: 15987650 [PubMed - indexed for MEDLINE]Related articles

Causal pathways of the effects of age and the CCR5-Delta32, CCR2-64I, and SDF-1 3'A alleles on AIDS development.

Geskus RB, Meyer L, Hubert JB, Schuitemaker H, Berkhout B, Rouzioux C, Theodorou ID, Delfraissy JF, Prins M, Coutinho RA.

J Acquir Immune Defic Syndr. 2005 Jul 1;39(3):321-6.PMID: 15980693 [PubMed - indexed for MEDLINE]Related articles

Sensitivity of primary R5 HTV-1 to inhibition by RANTES correlates with sensitivity to small-molecule R5 inhibitors.

Koning FA, Koevoets C, van der Vorst TJ, Schuitemaker H.

Antivir Ther. 2005;10(2):231-7.PMID: 15865217 [PubMed - indexed for MEDLINE]Related articles

Low levels of human immunodeficiency virus type 1 DNA in high-risk seronegative men.

Koning FA, van der Vorst TJ, Schuitemaker H.

J Virol. 2005 May;79(10):6551-3.PMID: 15858041 [PubMed - indexed for MEDLINE]Related articlesFree article

GB virus C coinfection and HIV-1 disease progression: The Amsterdam Cohort Study.

Van der Bij AK, Kloosterboer N, Prins M, Boeser-Nunnink B, Geskus RB, Lange JM, Coutinho RA, Schuitemaker H.

J Infect Dis. 2005 Mar 1;191(5):678-85. Epub 2005 Jan 28.PMID: 15688280 [PubMed - indexed for MEDLINE]Related articles

CCR5, GPR15, and CXCR6 are major coreceptors of human immunodeficiency virus type 2 variants isolated from individuals with and without plasma viremia.

Blaak H, Boers PH, Gruters RA, Schuitemaker H, van der Ende ME, Osterhaus AD.

J Virol. 2005 Feb;79(3):1686-700.PMID: 15650194 [PubMed - indexed for MEDLINE]Related articlesFree article

R5 human immunodeficiency virus type 1 infection of fetal thymic organ culture induces cytokine and CCR5 expression.

Choudhary SK, Choudhary NR, Kimbrell KC, Colasanti J, Ziogas A, Kwa D, Schuitemaker H, Camerini D.

J Virol. 2005 Jan;79(1):458-71.PMID: 15596839 [PubMed - indexed for MEDLINE]Related articlesFree article

Highly active antiretroviral therapy with or without mycophenolate mofetil in treatment-naive HIV-1 patients.

Sankatsing SU, Jurriaans S, van Swieten P, van Leth F, Cornelissen M, Miedema F, Lange JM, Schuitemaker H, Prins JM.

AIDS. 2004 Sep 24;18(14):1925-31.PMID: 15353978 [PubMed - indexed for MEDLINE]Related articles

HIV-1 seroreversion in an HIV-1-seropositive patient treated during acute infection with highly active antiretroviral therapy and mycophenolate mofetil.

Jurriaans S, Sankatsing SU, Prins JM, Schuitemaker H, Lange J, Van Der Kuyl AC, Cornelissen M.

AIDS. 2004 Jul 23;18(11):1607-8. No abstract available. PMID: 15238784 [PubMed - indexed for MEDLINE]Related articles

Correlates of resistance to HIV-1 infection in homosexual men with high-risk sexual behaviour.

Koning FA, Jansen CA, Dekker J, Kaslow RA, Dukers N, van Baarle D, Prins M, Schuitemaker H.

AIDS. 2004 May 21;18(8):1117-26.PMID: 15166527 [PubMed - indexed for MEDLINE]Related articles

Increased sensitivity to CD4 binding site-directed neutralization following in vitro propagation on primary lymphocytes of a neutralization-resistant human immunodeficiency virus IIIB strain isolated from an accidentally infected laboratory worker.

Beaumont T, Quakkelaar E, van Nuenen A, Pantophlet R, Schuitemaker H.

J Virol. 2004 Jun;78(11):5651-7.PMID: 15140962 [PubMed - indexed for MEDLINE]Related articlesFree article